Menitorix™

BIOLOGICAL2 trials

Sponsors

GlaxoSmithKline

Conditions

Haemophilus Influenzae Type bNeisseria Meningitidis

Phase 2

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

CompletedNCT00871338

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2009-06-24End: 2010-12-09Updated: 2018-06-06

Phase 3

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

CompletedNCT00586612

GlaxoSmithKlineHaemophilus Influenzae Type b, Neisseria Meningitidis

Start: 2007-12-01End: 2008-12-30Updated: 2018-08-27